This ADRC is an integrated unit of Washington University that coordinates and supports the work of established investigators and teachers from diverse backgrounds. Mechanisms are provided for the support of programs and projects with a focus on both clinical and basic science research, and the development of improved training of professionals within the University and outreach programs for health care professionals and the public in the regional community. The clinical theme of the research component in this application is the identification and characterization of mild and very mild dementia of the Alzheimer type (DAT) in comparison with healthy aging.The basic science theme is the characterization of neurobiological principles and mechanisms relevant to aging of the nervous system and neuronal dysfunction and/or death in Alzheimer's disease (AD). Five cores (Biostatistics, Clinical, Psychometric, Neuropathology/Tissue Resource, Administration) will support five projects and five pilots. The topics of the projects include: 1) ApoE clearance receptor in CNS; 2) cellular prion proteins; 3) gene expression and neuronal vulnerability in neurodegenerative disease; 4) molecular genetics of dementia; and 5) processing speed, working memory and fluid cognitive abilities in DAT. The pilots study: 1) structure of the A-beta-protein; 2) AD and fibroblast bradykinin receptor modulation; 3) an AMPA receptor modulatory site; 4) protein fatty acylation in neuronal growth and remodeling; and 5) cognitive deficits and speech perception in DAT. A Training and Information-Transfer core supports our educational activities. Two Satellite components reach out to African Americans in our community and to the underserved rural areas of our region. This ADRC also interacts with and supports other investigators at this University, funded through other mechanisms, in order to focus attention on issues relevant to aging, AD and other dementias. Finally, the ADRC interacts with other Centers and the Alzheimer's Association to coordinate our efforts.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
2P50AG005681-12
Application #
2049265
Study Section
Special Emphasis Panel (ZAG1-DAG-4 (52))
Project Start
1985-09-30
Project End
2000-04-30
Budget Start
1995-05-01
Budget End
1996-04-30
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Washington University
Department
Neurology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Ibanez, Laura; Dube, Umber; Davis, Albert A et al. (2018) Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease. Front Neurosci 12:230
Schindler, Suzanne E; Gray, Julia D; Gordon, Brian A et al. (2018) Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimers Dement 14:1460-1469
Roe, Catherine M; Babulal, Ganesh M; Mishra, Shruti et al. (2018) Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. J Alzheimers Dis 61:509-513
Agogo, George O; Ramsey, Christine M; Gnjidic, Danijela et al. (2018) Longitudinal associations between different dementia diagnoses and medication use jointly accounting for dropout. Int Psychogeriatr 30:1477-1487
Weintraub, Sandra; Besser, Lilah; Dodge, Hiroko H et al. (2018) Version 3 of the Alzheimer Disease Centers' Neuropsychological Test Battery in the Uniform Data Set (UDS). Alzheimer Dis Assoc Disord 32:10-17
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Broce, Iris; Karch, Celeste M; Wen, Natalie et al. (2018) Correction: Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies. PLoS Med 15:e1002504
Lucey, Brendan P; Hicks, Terry J; McLeland, Jennifer S et al. (2018) Effect of sleep on overnight cerebrospinal fluid amyloid ? kinetics. Ann Neurol 83:197-204
Armstrong, Richard A; McKee, Ann C; Stein, Thor D et al. (2018) Cortical degeneration in chronic traumatic encephalopathy and Alzheimer's disease neuropathologic change. Neurol Sci :
Liao, Fan; Li, Aimin; Xiong, Monica et al. (2018) Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Invest 128:2144-2155

Showing the most recent 10 out of 952 publications